Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non-small cell lung cancer.
Arrieta O, Aviles-Salas A, Orozco-Morales M, Hernández-Pedro N, Cardona AF, Cabrera-Miranda L, Barrios-Bernal P, Soca-Chafre G, Cruz-Rico G, Peña-Torres ML, Moncada-Claudio G, Ramirez-Tirado LA. Arrieta O, et al. Among authors: cruz rico g. Cancer Med. 2020 Apr;9(7):2390-2402. doi: 10.1002/cam4.2882. Epub 2020 Feb 11. Cancer Med. 2020. PMID: 32043750 Free PMC article.
Modifying factors of PD-L1 expression on tumor cells in advanced non-small-cell lung cancer.
Avilés-Salas A, Flores-Estrada D, Lara-Mejía L, Catalán R, Cruz-Rico G, Orozco-Morales M, Heredia D, Bolaño-Guerra L, Soberanis-Piña PD, Varela-Santoyo E, Cardona AF, Arrieta O. Avilés-Salas A, et al. Among authors: cruz rico g. Thorac Cancer. 2022 Dec;13(23):3362-3373. doi: 10.1111/1759-7714.14695. Epub 2022 Oct 31. Thorac Cancer. 2022. PMID: 36317227 Free PMC article.
A high number of co-occurring genomic alterations detected by NGS is associated with worse clinical outcomes in advanced EGFR-mutant lung adenocarcinoma: Data from LATAM population.
Heredia D, Mas L, Cardona AF, Oyervides V, Motta Guerrero R, Galvez-Nino M, Lara-Mejía L, Aliaga-Macha C, Carracedo C, Varela-Santoyo E, Ramos-Ramírez M, Davila-Dupont D, Martínez J, Cruz-Rico G, Remon J, Arrieta O. Heredia D, et al. Among authors: cruz rico g. Lung Cancer. 2022 Dec;174:133-140. doi: 10.1016/j.lungcan.2022.11.002. Epub 2022 Nov 9. Lung Cancer. 2022. PMID: 36379126
[Personalized treatment in non-small cell lung cancer].
Campos-Parra AD, Cruz-Rico G, Arrieta O. Campos-Parra AD, et al. Rev Invest Clin. 2012 Jul-Aug;64(4):377-86. Rev Invest Clin. 2012. PMID: 23227588 Review. Spanish. No abstract available.
Response rate of patients with baseline brain metastases from recently diagnosed non-small cell lung cancer receiving radiotherapy according to EGFR, ALK and KRAS mutation status.
Arrieta O, Ramírez-Tirado LA, Caballé-Perez E, Mejia-Perez A, Zatarain-Barrón ZL, Cardona AF, Lozano-Ruíz F, Segura-González M, Cruz-Rico G, Maldonado F, Rosell R. Arrieta O, et al. Among authors: cruz rico g. Thorac Cancer. 2020 Apr;11(4):1026-1037. doi: 10.1111/1759-7714.13359. Epub 2020 Feb 19. Thorac Cancer. 2020. PMID: 32072746 Free PMC article.
Association of Lung Adenocarcinoma Subtypes According to the IASLC/ATS/ERS Classification and Programmed Cell Death Ligand 1 (PD-L1) Expression in Tumor Cells.
Cruz-Rico G, Avilés-Salas A, Popa-Navarro X, Lara-Mejía L, Catalán R, Sánchez-Reyes R, López-Sánchez D, Cabrera-Miranda L, Aquiles Maldonado-Martínez H, Samtani-Bassarmal S, Arrieta O. Cruz-Rico G, et al. Pathol Oncol Res. 2021 Apr 8;27:597499. doi: 10.3389/pore.2021.597499. eCollection 2021. Pathol Oncol Res. 2021. PMID: 34257548 Free PMC article.
Cell-Free Circulating Tumor DNA Improves Standard Genotyping of Non-Small-Cell Lung Cancer and Increases Detection of Targetable Alterations in a Selected Hispanic Cohort.
Zatarain-Barrón ZL, Cardona AF, Díaz-García D, Trejo Rosales R, Rojas L, Cruz-Rico G, Nagy R, Cabrera L, Vargas C, Saam J, Barrón F, Arrieta O. Zatarain-Barrón ZL, et al. Among authors: cruz rico g. Oncology. 2021;99(8):539-546. doi: 10.1159/000514648. Epub 2021 Apr 26. Oncology. 2021. PMID: 33902046
16 results